Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Zvi Steinberg who wrote (194)	11/11/1998 11:28:00 PM
From: Ariella	Read Replies (1) \| Respond to of 1386

I posed this issue to Gadi on the August conference call. He replied emphatically that he expected no problem introducing a cannabinoid into the US. I think it's inevitable that the press will give us a "high" twist and, actually, that's one good thing about being so low on everybody's radar screen at the moment. The cultural bias against marijuana-related drugs in the US and England is also one of the reasons all these researchers are so far behind PARS in drug development from this source. -Ariella